Pular para o conteúdo principal
Ranking Invest

CBLI - Cytocom, Inc.

Segmento: HealthcareCleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. The company is headquartered in Buffalo, New York and currently employs 15 full-time employees. The firm is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.

Análise Ranking Invest

Valuation estimado
$ 3.81 Mi
Último Balanço Atualizado: 2T2021

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 13.53 Mi

Dívida Líquida

-$ 13.78 Mi

L4T

-$ 2.64 Mi

MM4T

-66050687984849.39%

Indicadores Básicos

ROE

-19.50%

Índices de Previsibilidade

Receita Líquida

F0.47

Lucro

B0.23

Margem

D0.66

Índices de Tendência

Receita Líquida

F-10.26

Lucro

A8.43

Margem

E-1.62

Índices de Endividamento

DIV/PAT

-1.02

DIV/L4T

5.22

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.